Anna Plechanovová

2.4k total citations · 1 hit paper
16 papers, 1.9k citations indexed

About

Anna Plechanovová is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Anna Plechanovová has authored 16 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 9 papers in Oncology and 2 papers in Cellular and Molecular Neuroscience. Recurrent topics in Anna Plechanovová's work include Ubiquitin and proteasome pathways (11 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer-related Molecular Pathways (5 papers). Anna Plechanovová is often cited by papers focused on Ubiquitin and proteasome pathways (11 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer-related Molecular Pathways (5 papers). Anna Plechanovová collaborates with scholars based in United Kingdom, United States and Czechia. Anna Plechanovová's co-authors include Ronald T. Hay, Ellis Jaffray, Michael H. Tatham, James H. Naismith, Neil Hattersley, Marie‐Claude Geoffroy, Linnan Shen, Jorma J. Palvimo, Ivan Matić and Roland Bruderer and has published in prestigious journals such as Nature, Nature Communications and The Journal of Cell Biology.

In The Last Decade

Anna Plechanovová

16 papers receiving 1.9k citations

Hit Papers

RNF4 is a poly-SUMO-speci... 2008 2026 2014 2020 2008 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Plechanovová United Kingdom 13 1.7k 735 220 206 196 16 1.9k
Danny T. Huang United Kingdom 22 2.5k 1.5× 1.1k 1.5× 566 2.6× 261 1.3× 333 1.7× 49 2.8k
Andrea Pichler Germany 18 2.5k 1.5× 847 1.2× 208 0.9× 290 1.4× 246 1.3× 37 2.8k
Beatrice Bercovich Israel 17 1.3k 0.7× 526 0.7× 276 1.3× 176 0.9× 292 1.5× 19 1.5k
Ivo A. Hendriks Denmark 24 2.7k 1.6× 1.2k 1.6× 187 0.8× 393 1.9× 298 1.5× 52 3.1k
Linnan Shen United Kingdom 9 1.3k 0.7× 470 0.6× 198 0.9× 125 0.6× 144 0.7× 10 1.3k
Christine Yu United States 15 1.3k 0.8× 383 0.5× 354 1.6× 303 1.5× 205 1.0× 21 1.7k
Hung Phi Nguyen United States 7 1.1k 0.6× 298 0.4× 188 0.9× 195 0.9× 122 0.6× 7 1.2k
Tycho E.T. Mevissen United Kingdom 15 2.2k 1.3× 682 0.9× 564 2.6× 303 1.5× 347 1.8× 16 2.5k
Yaron Galanty United Kingdom 20 2.9k 1.7× 1.0k 1.4× 146 0.7× 151 0.7× 263 1.3× 27 3.1k
Lorenza Penengo Switzerland 22 1.5k 0.9× 563 0.8× 169 0.8× 227 1.1× 248 1.3× 27 1.9k

Countries citing papers authored by Anna Plechanovová

Since Specialization
Citations

This map shows the geographic impact of Anna Plechanovová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Plechanovová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Plechanovová more than expected).

Fields of papers citing papers by Anna Plechanovová

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Plechanovová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Plechanovová. The network helps show where Anna Plechanovová may publish in the future.

Co-authorship network of co-authors of Anna Plechanovová

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Plechanovová. A scholar is included among the top collaborators of Anna Plechanovová based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Plechanovová. Anna Plechanovová is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Jaffray, Ellis, Michael H. Tatham, Barbara Mojsa, et al.. (2025). PML mutants from arsenic-resistant patients reveal SUMO1-TOPORS and SUMO2/3-RNF4 degradation pathways. The Journal of Cell Biology. 224(6). 1 indexed citations
2.
Murphy, Paul, Yingqi Xu, Sarah L. Rouse, et al.. (2020). Functional 3D architecture in an intrinsically disordered E3 ligase domain facilitates ubiquitin transfer. Nature Communications. 11(1). 3807–3807. 8 indexed citations
3.
Branigan, Emma, Anna Plechanovová, & Ronald T. Hay. (2019). Methods to analyze STUbL activity. Methods in enzymology on CD-ROM/Methods in enzymology. 618. 257–280. 4 indexed citations
4.
Branigan, Emma, Anna Plechanovová, Ellis Jaffray, James H. Naismith, & Ronald T. Hay. (2015). Structural basis for the RING-catalyzed synthesis of K63-linked ubiquitin chains. Nature Structural & Molecular Biology. 22(8). 597–602. 92 indexed citations
5.
Xu, Yingqi, Anna Plechanovová, P. J. Simpson, et al.. (2014). Structural insight into SUMO chain recognition and manipulation by the ubiquitin ligase RNF4. Nature Communications. 5(1). 4217–4217. 38 indexed citations
6.
Rojas‐Fernández, Alejandro, Anna Plechanovová, Neil Hattersley, et al.. (2014). SUMO Chain-Induced Dimerization Activates RNF4. Molecular Cell. 53(6). 880–892. 63 indexed citations
7.
Tatham, Michael H., et al.. (2013). Ube2W conjugates ubiquitin to α-amino groups of protein N-termini. Biochemical Journal. 453(1). 137–145. 88 indexed citations
8.
Plechanovová, Anna, Ellis Jaffray, Michael H. Tatham, James H. Naismith, & Ronald T. Hay. (2012). Structure of a RING E3 ligase and ubiquitin-loaded E2 primed for catalysis. Nature. 489(7414). 115–120. 431 indexed citations
9.
Plechanovová, Anna, Ellis Jaffray, S.A. McMahon, et al.. (2011). Mechanism of ubiquitylation by dimeric RING ligase RNF4. Nature Structural & Molecular Biology. 18(9). 1052–1059. 142 indexed citations
10.
Plechanovová, Anna, Youngjoo Byun, Glenda Alquicer, et al.. (2011). Novel Substrate-Based Inhibitors of Human Glutamate Carboxypeptidase II with Enhanced Lipophilicity. Journal of Medicinal Chemistry. 54(21). 7535–7546. 21 indexed citations
11.
Bruderer, Roland, et al.. (2011). Purification and identification of endogenous polySUMO conjugates. EMBO Reports. 12(2). 142–148. 139 indexed citations
12.
Colbert, Jeff D., Anna Plechanovová, & Colin Watts. (2009). Glycosylation Directs Targeting and Activation of Cystatin F from Intracellular and Extracellular Sources. Traffic. 10(4). 425–437. 46 indexed citations
13.
Klusák, Vojtěch, Cyril Bařinka, Anna Plechanovová, et al.. (2009). Reaction Mechanism of Glutamate Carboxypeptidase II Revealed by Mutagenesis, X-ray Crystallography, and Computational Methods. Biochemistry. 48(19). 4126–4138. 46 indexed citations
14.
Tatham, Michael H., Marie‐Claude Geoffroy, Linnan Shen, et al.. (2008). RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation. Nature Cell Biology. 10(5). 538–546. 678 indexed citations breakdown →
15.
Mlčochová, Petra, Anna Plechanovová, Cyril Bařinka, et al.. (2007). Mapping of the active site of glutamate carboxypeptidase II by site‐directed mutagenesis. FEBS Journal. 274(18). 4731–4741. 21 indexed citations
16.
Bařinka, Cyril, Petra Mlčochová, Klára Hlouchová, et al.. (2007). Structural Insight into the Pharmacophore Pocket of Human Glutamate Carboxypeptidase II. Journal of Medicinal Chemistry. 50(14). 3267–3273. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026